Participants who took tirzepatide — which is sold as Zepbound by Eli Lilly — lost an average of 50 pounds over 72 weeks.

Nearly 32% of Zepbound users lost at least a quarter of their body weight, compared with about 16% of Wegovy users. In both ...

Mounjaro, manufactured by US drugmaker, and Wegovy by Danish drugmaker Novo Nordisk, cause weight loss by suppressing the ...

Pfizer shares were up 2.2%, Eli Lilly shares were up 2.9% ... generic drugs directly to consumers and recently signed a deal ...

A listeria outbreak linked to ready-to-eat sandwiches and snacks has sickened at least 10 people in the U.S., and a producer ...

Investing.com - Global pharmaceutical stocks were mixed Monday after U.S. President Donald Trump signed an executive order aimed at reducing prescription drug prices in the United States by between 30 ...